VTVT IPOs 8.98M* shares @$15.00: http://finance.yahoo.com/news/vtv-therapeutics-inc-announces-pricing-014700716.html vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness. *Assuming exercise of underwriter’s option.